Log in
Pharmacology · Hormone preparations, their synthetic substitutes, and antagonists

Antiandrogens

Antiandrogena

Antiandrogen drugs suppress male sex hormones in two ways: by disrupting their synthesis or by blocking receptor binding. They are used in medical practice for benign prostatic hyperplasia and other endocrine disorders.

Finasteride5α-reductase inhibitor (trade name Proscar)
Target organsProstate gland and external genitalia
Mechanisms of actionDisruption of synthesis and receptor blockade
ClassificationBlockers are divided into two groups based on structure
2 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Mechanisms of antiandrogen action

Pharmacological agents of this group exert their effects through two main pathways:

  • Disruption of androgen hormone synthesis in the body.
  • Direct blockade of androgen binding to sensitive receptors.

The selectivity of these agents' effects is strictly limited to tissues where hormonal activity is mediated predominantly by dihydrotestosterone. The main targets for their action are the prostate gland and external genitalia.

Androgen synthesis inhibitors

A prominent representative of synthesis inhibitors is Finasteride (known under the trade name Proscar).

  • Pharmacodynamics: the drug selectively inhibits the enzyme $5\alpha$-reductase, and its action is tissue-specific, manifesting in the prostate gland.
  • Chain of effects: blockade of the enzyme leads to impaired conversion of testosterone into active dihydrotestosterone $\rightarrow$ reduced stimulation of prostate cell proliferation $\rightarrow$ a decrease in overall gland size.
  • Administration: the drug is taken orally (per os) and is the primary agent for the treatment of benign prostatic hyperplasia (BPH).
Test your knowledge on the topicTasks from the «Pharmacology» course bank — instant answers and explanations.

Classification of receptor blockers

Drugs that block androgen receptors are divided into two main groups. Their categorization is based on chemical structure features and the specific mechanism of interaction with the body's cellular receptors.

Briefly: answers to topical questions

What are the two groups into which androgen receptor blockers are divided?

Androgen receptor blockers are divided into two groups depending on their chemical structure and mechanism of interaction with receptors. Based on this classification, the following main groups of drugs are distinguished:

  • Steroid drugs — derivatives of progesterone.
  • Non-steroidal competitive antagonists — synthetic non-steroidal antiandrogens that compete with natural hormones for binding to receptors in target organs.

Which drugs belong to steroid antiandrogens?

Steroid antiandrogenic drugs include cyproterone, a progesterone derivative.

  • Cyproterone (Cyproterone) is a steroid drug. It is a partial agonist of androgen receptors with antiandrogenic activity, suppresses the secretion of pituitary gonadotropic hormones, and reduces the effects of androgens in tissues.

Which drugs belong to non-steroidal antiandrogens?

The group of synthetic non-steroidal antiandrogens includes competitive antagonists used for the treatment of prostate cancer. This group includes the following drugs:

  • Flutamide (Flutamide) — competitively blocks androgen binding to receptors and suppresses the inhibitory effect of testosterone on gonadotropin secretion.
  • Bicalutamide (Bicalutamide) — a non-steroidal competitive antagonist that blocks androgen binding.
  • Nilutamide — a synthetic non-steroidal antiandrogen.
How to memorize

FINAsteride: FINA-lizes (reduces) the prostate by blocking 5-alpha-reductase and the conversion of testosterone to dihydrotestosterone.

Class and exam questions

What are the two main mechanisms of action of antiandrogen drugs?

Drugs act by disrupting the synthesis of androgen hormones or by blocking the binding of androgens to cellular receptors.

Which enzyme does finasteride inhibit, and what is its localization?

Finasteride inhibits the enzyme 5α-reductase, and its action is tissue-specific, manifesting in the prostate gland.

What is the primary indication for the use of finasteride?

The primary indication is benign prostatic hyperplasia (BPH); the drug is taken orally.

Unclear? Ask the AIThe AI tutor has reviewed the material on "Antiandrogens" and will explain it in simple terms.

What else to study on this topic

  • Detailed analysis of the clinical pharmacology of Cyproterone
  • Study of the two groups of androgen receptor blockers by chemical structure
  • Use of the antiestrogen clomifene in anovulatory infertility
  • Use of the gonadotropin synthesis inhibitor danazol in endometriosis
  • Peculiarities of thiamazole use in hyperthyroidism

Master the entire topic in the «Pharmacology» course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Antiandrogens" and 5,304 more pages of the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 116 video lessons on the subject

Other topics in the section "Hormone preparations, their synthetic substitutes, and antagonists"

Entire section "Hormone preparations, their synthetic substitutes, and antagonists"

Free video lessons: pharmacologyShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.